Significance of glycated LDL in different stages of diabetic nephropathy

This publication has 11 references indexed in Scilit:

• Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications
  Journal of Diabetes & Metabolic Disorders, 2016
• Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus
  Diabetes/Metabolism Research and Reviews, 2016
• Changes in Diabetes-Related Complications in the United States, 1990–2010
  New England Journal of Medicine, 2014
• Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
  Diabetes & Metabolism Journal, 2014
• Medical Care Costs Associated With Progression of Diabetic Nephropathy
  Diabetes Care, 2011
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
  Epidemiology, 2007
• Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: Pathogenic and therapeutic implications
  Journal of Laboratory and Clinical Medicine, 2006
• Increased Plasma Glycated Low-Density Lipoprotein Concentrations in Diabetes: A Marker of Atherogenic Risk
  Diabetes Technology & Therapeutics, 2004
• Prevalence of Kidney Damage in Australian Adults
  Journal of the American Society of Nephrology, 2003
• Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait
  Clinica Chimica Acta, 2001